Gene · 4680
Papers1,711
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,711
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulatory roles of NAT10 in airway epithelial cell function and metabolism in pathological conditions. | Cell Biol Toxicol | 2023 | 35877022 | PubTator, text mining | PubMed |
| The next "sweet" spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection. | Mass Spectrom Rev | 2023 | 34766650 | PubTator, text mining | PubMed |
| Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker. | F1000Res | 2022 | 39239252 | PubTator, text mining | PubMed |
| Immune cell-specific smoking-related expression characteristics are revealed by re-analysis of transcriptomes from the CEDAR cohort. | Cent Eur J Immunol | 2022 | 36817262 | PubTator, text mining | PubMed |
| The tamoxifen-regulated, long non-coding RNA LINC00992 affects proliferation, migration, and expression of tamoxifen resistance-associated genes in MCF-7 breast cancer cells. | Contemp Oncol (Pozn) | 2022 | 36816389 | PubTator, text mining | PubMed |
| Recursive Feature Elimination-based Biomarker Identification for Open Neural Tube Defects. | Curr Genomics | 2022 | 36777008 | PubTator, text mining | PubMed |
| Rhinovirus increases Moraxella catarrhalis adhesion to the respiratory epithelium. | Front Cell Infect Microbiol | 2022 | 36733852 | PubTator, text mining | PubMed |
| Functional impact of multi-omic interactions in breast cancer subtypes. | Front Genet | 2022 | 36685900 | PubTator, text mining | PubMed |
| Active Targeting of Versatile Nanocomplex Using the Novel Biomarker of Breast Cancer Stem Cells. | Int J Mol Sci | 2022 | 36614128 | PubTator, text mining | PubMed |
| Simulated Microgravity Influences Immunity-Related Biomarkers in Lung Cancer. | Int J Mol Sci | 2022 | 36613598 | PubTator, text mining | PubMed |
| Enhancing CAR T-cell therapies against solid tumors: Mechanisms and reversion of resistance. | Front Immunol | 2022 | 36569859 | PubTator, text mining | PubMed |
| Diverse Neutrophil Functions in Cancer and Promising Neutrophil-Based Cancer Therapies. | Int J Mol Sci | 2022 | 36555469 | PubTator, text mining | PubMed |
| Interplay between Serotonin, Immune Response, and Intestinal Dysbiosis in Inflammatory Bowel Disease. | Int J Mol Sci | 2022 | 36555276 | PubTator, text mining | PubMed |
| Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD. | BMC Med Genomics | 2022 | 36522691 | PubTator, text mining | PubMed |
| GOLM1 and FAM49B: Potential Biomarkers in HNSCC Based on Bioinformatics and Immunohistochemical Analysis. | Int J Mol Sci | 2022 | 36499755 | PubTator, text mining | PubMed |
| Quantitative proteomic analysis of SARS-CoV-2 infection of primary human airway ciliated cells and lung epithelial cells demonstrates the effectiveness of SARS-CoV-2 innate immune evasion. | Wellcome Open Res | 2022 | 36483314 | PubTator, text mining | PubMed |
| Back to basic: Trials and tribulations of alkalizing agents in cancer. | Front Oncol | 2022 | 36452492 | PubTator, text mining | PubMed |
| Prebiotic/probiotic supplementation resulted in reduced visceral fat and mRNA expression associated with adipose tissue inflammation, systemic inflammation, and chronic disease risk. | Genes Nutr | 2022 | 36437471 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Identifies Tumor Cell Surface Targets for CAR-T Cell Therapies and Antibody Drug Conjugates. | Cancers (Basel) | 2022 | 36428765 | PubTator, text mining | PubMed |
| Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36428603 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4680/papers?page=18